Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 22, 2015 11:04 PM ET

Pharmaceuticals

Company Overview of Novartis AG

Executive Profile

Enrico Vanni Ph.D.

Vice Chairman, Chairman of Compensation Committee, Member of Audit & Compliance Committee and Member of Research & Development Committee, Novartis AG
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 3 different industries.

See Board Relationships
63$546,173

Background

Dr. Enrico Vanni, Ph.D., serves as an Independent Consultant of Eclosion (private equity for biotechs), Denzler&Partners (management resources) and Mbcp (private banking). Dr. Vanni has more than 30 years of healthcare management experience. He served as head of the European pharmaceutical practice for McKinsey&Company. He started his career in 1977 with IBM in San Jose, California, and joined McKinsey & Company in Zurich, Switzerland. He managed the Geneva Office from ...

Corporate Headquarters

Lichtstrasse 35
Basel, Basel-Stadt 4056

Switzerland

Phone: 41 61 324 11 11
Fax: --

Board Members Memberships

2010-Present
Director, Member of Audit Committee and Member of Nominating/Corporate Governance Committee
2011-Present
Vice Chairman, Chairman of Compensation Committee, Member of Audit & Compliance Committee and Member of Research & Development Committee
2013-Present
Non-Executive Director

Education

MBA
INSEAD
PhD
Université de Lausanne

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$278,673
Total Calculated Compensation$546,173
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Alex Gorsky Chairman, Chief Executive Officer, Chairman of Executive Committee and Chairman of Finance Committee
Johnson & Johnson
$1.5M
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
$1.8M
Kenneth C. Frazier Chairman, Chief Executive Officer and President
Merck & Co. Inc.
$1.5M
Severin Schwan Ph.D.Chief Executive Officer and Director
Roche Holding AG
$5.3M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Novartis AG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.